Emphasis on Product (Coronary Stents, Peripheral Stents, EVAR Stent-Grafts, Others); Type (Bare-Metal Stents, Drug-Eluting Stents, Bioabsorbable Stents); Mode of Delivery (Balloon-Expandable Stents, Self-expanding Stents); End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, and Others); Region/Country
Global Vascular Stent Market is anticipated to grow with an elevated CAGR of around 7% over the forecast period (2021-2027). The technological advancements in vascular stents are accompanied by the increasing prevalence of cardiovascular diseases and heart failure. Furthermore, the changing lifestyle preferences in children and adolescents are responsible for the rising number of diseases such as obesity and diabetes that can cause heart attacks are also responsible for the growth of the vascular stent market. For instance, as per CDC, the prevalence of obesity was 19.7% and affected about 14.7 million children and adolescents. Obesity prevalence was 12.7% among 2 to 5-year-olds, 20.7% among 6 to 11-year-olds, and 22.2% among 12 to 19-year-olds. Moreover, the rising geriatric population is also responsible for the rising cardiac disorders that result in rising demand for the vascular stent.
Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific Corporation, C. R. Bard, Inc., and Cook Medical are some of the key players operating in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new varieties of vascular stent.
Insights Presented in the Report
“Amongst Type, drug-eluting stents segment holds the major share”
Based on the type, the market is categorized into bare-metal stents, drug-eluting stents, and bioabsorbable stents. The drug-eluting stents segment held a significant market in 2020 and it is anticipated to grow during the forecast period. The rapidly increasing number of cases of coronary heart disease induces the demand for a better and improved version of the stents responsible for the segmental growth of drug-eluting stents. Furthermore, frequent launches of new-generation stents are responsible for the segmental growth of drug-eluting stents. For instance, in May 2022, Medtronic plc, announced it received U.S. Food and Drug Administration (FDA) approval for the Onyx Frontier™ drug-eluting stent (DES). Onyx Frontier DES leverages the same best-in-class stent platform as Resolute Onyx™ DES, with an enhanced delivery system designed to improve deliverability and increase acute performance in even the most challenging of cases.
“Amongst Mode of Delivery, balloon-expandable stents held the major share”
Based on the mode of delivery, the market is segmented into balloon-expandable stents and self-expanding stents. The balloon-expandable stents held a significant market share and are anticipated to witness significant growth during the forecast period. This is mainly due to the increasing complexity of heart surgeries and their accuracy during the stent placement. Furthermore, the advancement in stent technology also favors the growth of the segment in the vascular stent market. For instance, in November 2021, the Robert Wood Johnson University Hospital treated a patient with the new drug-coated balloon angioplasty therapy named AGENT™ Drug-Coated Balloon (DCB), a minimally invasive coronary angioplasty balloon catheter, to treat a 77-year-old patient whose artery had repeatedly narrowed again after several previous angioplasty treatments with drug-eluting stents.
“Amongst End-users, hospitals & clinics holds the major share”
Based on end-user, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics are predicted to have considerable market growth during the forecast period. This is due to the specialization in heart disease treatments along with the presence of specialized staff. Furthermore, the integration of advanced technology such as AI-based equipment and electronic patient records attributes to the growth of the hospitals and clinics in the vascular stent market. For instance, ClinOme is a Graphical User Interface (GUI) based automated tool developed by senior scientists & clinicians from ACTREC & Tata Memorial Hospital. It automates quality check, primary, secondary and tertiary analysis of raw NGS data followed by report generation that can be easily comprehended by the clinicians.
“North America represents one of the largest markets of vascular stent market”
For a better understanding of the market adoption of the vascular stent, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America grabbed a significant market share of the global vascular stent market in 2020. It is expected to grow with a considerable CAGR during the forecast period. The major factors such as sophisticated healthcare infrastructure, the presence of a large population, the rise in cardiac disease incidence, the aging population, the rising prevalence of peripheral arterial disease, and increasing investments by investors are propelling the growth of this market. For instance, as per CDC, approximately 8 million people in the United States have peripheral arterial disease, including 12-20% of individuals older than age 60.
Reasons to buy this report:
Customization Options:
The global vascular stent market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption 2 Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Global Vascular Stent Market Covid-19 Impact
6. Global Vascular Stent Market Revenue, 2019-2027f
7. Market Insights By Product
8. Market Insights By Type
9. Market Insights By Mode Of Delivery
10. Market Insights By End-users
11. Market Insights By Region
12. Vascular Stent Market Dynamics
13. Vascular Stent Market Opportunities
14. Vascular Stent Market Trends
15. Legal & Regulatory Framework
16. Demand And Supply-side Analysis
17. Value Chain Analysis
18. Competitive Scenario
19. Company Profiled
20. Disclaimer
Research Methodology for the Global Vascular stent Market Analysis (2021-2027)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global vascular stent market were the three major steps undertaken to create and analyze the adoption of the vascular stent in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global vascular stent market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the Vascular stent through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications
Step 2: Market Segmentation:
After obtaining the historical market size of the Vascular stent market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report as product, type, mode of delivery, and end-users. Further country-level analyses were conducted to evaluate the overall adoption of the vascular stent across the globe.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the vascular stent. Further, we conducted factor analysis using dependent and independent variables such as the growing number of people with chronic diseases and the increasing elderly population all over the globe. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Vascular stent sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the vascular stent market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the vascular stent market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product, type, mode of delivery, and end-users of the vascular stent market.
The main objective of the vascular stent market study
The current & future market trends of the vascular stent were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
